The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

References

• CelliBRDecramerMWedzichaJAAn official American Thoracic Society/European Respiratory Society statement: research questions in COPDEur Respir Rev20152415917226028628
   PubMed Web of Science ®Google Scholar
• DewarMCurryRWJrChronic obstructive pulmonary disease: diagnostic considerationsAm Fam Physician20067366967616506711
   PubMed Web of Science ®Google Scholar
• JanssensWLehouckADecramerMVitamin D and the Lung: Mechanisms and Disease AssociationsMassachusettsSpringer2012239260
   Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• DecramerMDeBFDelPASystemic effects of COPDRespir Med200599suppl BS3S1016219454
   PubMed Web of Science ®Google Scholar
• LavenezianaPPalangePPhysical activity, nutritional status and systemic inflammation in COPDEur Respir J20124052252922941542
   PubMed Web of Science ®Google Scholar
• BrusselleGGJoosGFBrackeKRNew insights into the immunology of chronic obstructive pulmonary diseaseLancet20113781015102621907865
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet200737078679617765528
   PubMed Web of Science ®Google Scholar
• WilsonRSethiSAnzuetoAAntibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary diseaseJ Infect20136749751523973659
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
   PubMed Web of Science ®Google Scholar
• WilsonRAnzuetoAMiravitllesMA novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodologyInt J Chron Obstruct Pulmon Dis2011637338321760724
   PubMed Web of Science ®Google Scholar
• DonathEChaudhryAHernandez-AyaLFA meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with chronic obstructive pulmonary diseaseRespir Med20131071385139223768735
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet200336144945612583942
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• CrinerGJBourbeauJDiekemperRLExecutive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest201514788389325320966
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLHartlSPozo-RodriguezFEuropean COPD audit: design, organisation of work and methodologyEur Respir J20134127027622599361
   PubMed Web of Science ®Google Scholar
• SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med20083592355236519038881
   PubMed Web of Science ®Google Scholar
• SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax20126795796322684094
   PubMed Web of Science ®Google Scholar
• CoemanMvanDYBautersFNeomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational studyTher Adv Respir Dis2011537738621890536
   PubMedGoogle Scholar
• KudohSAzumaAYamamotoMImprovement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycinAm J Respir Crit Care Med1998157182918329620913
   PubMed Web of Science ®Google Scholar
• SaimanLMarshallBCMayer-HamblettNAzithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trialJAMA20032901749175614519709
   PubMed Web of Science ®Google Scholar
• VosRVanaudenaerdeBMVerledenSEA randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantationEur Respir J20113716417220562124
   PubMed Web of Science ®Google Scholar
• WongCJayaramLKaralusNAzithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trialLancet201238066066722901887
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med201136568969821864166
   PubMed Web of Science ®Google Scholar
• WenzelRPFowlerAA3rdEdmondMBAntibiotic prevention of acute exacerbations of COPDN Engl J Med201236734034722830464
   PubMed Web of Science ®Google Scholar
• SimoensSLaekemanGDecramerMPreventing COPD exacerbations with macrolides: a review and budget impact analysisRespir Med201310763764823352223
   PubMed Web of Science ®Google Scholar
• SpagnoloPFabbriLMBushALong-term macrolide treatment for chronic respiratory diseaseEur Respir J20134223925123180583
   PubMed Web of Science ®Google Scholar
• Giamarellos-BourboulisEJPechereJCRoutsiCEffect of clarithromycin in patients with sepsis and ventilator-associated pneumoniaClin Infect Dis2008461157116418444850
   PubMed Web of Science ®Google Scholar
• JohnstonSLBlasiFBlackPNThe effect of telithromycin in acute exacerbations of asthmaN Engl J Med20063541589160016611950
   PubMed Web of Science ®Google Scholar
• global strategy for the diagnosis, management, and prevention of COPD: updated 2015Global Initiative for Chronic Obstructive Lung Disease2015 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed August 31, 2015
   Google Scholar
• LeuppiJDSchuetzPBingisserRShort-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJAMA20133092223223123695200
   PubMed Web of Science ®Google Scholar
• WaltersJAWangWMorleyCDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD00689721975757
   PubMed Web of Science ®Google Scholar
• ChengTGongYGuoYSystemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trialsClin Respir J2013730531823072733
   PubMed Web of Science ®Google Scholar
• ShepardRMFalknerFCPharmacokinetics of azithromycin in rats and dogsJ Antimicrob Chemother199025suppl A49602154438
   PubMed Web of Science ®Google Scholar
• FouldsGShepardRMJohnsonRBThe pharmacokinetics of azithromycin in human serum and tissuesJ Antimicrob Chemother199025suppl A73822154441
   PubMed Web of Science ®Google Scholar
• VosRVanaudenaerdeBMVerledenSEAnti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejectionTransplantation20129410110922461039
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med19993401941194710379017
   PubMed Web of Science ®Google Scholar
• VanRHRasteYLouvarisZValidity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetryPLoS One20127e3919822745715
   PubMed Web of Science ®Google Scholar
• LehouckAMathieuCCarremansCHigh doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trialAnn Intern Med201215610511422250141
   PubMed Web of Science ®Google Scholar
• WilsonRAnzuetoAMiravitllesMMoxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsEur Respir J201240172722135277
   PubMed Web of Science ®Google Scholar
• DeMetsDLLanKKInterim analysis: the alpha spending function approachStat Med199413134113527973215
   PubMed Web of Science ®Google Scholar
• BauerPRohmelJMaurerWTesting strategies in multi-dose experiments including active controlStat Med199817213321469789919
   PubMed Web of Science ®Google Scholar